FDA Approves New Antibiotic for Three Indications
MONDAY, April 8, 2024 -- The U.S. Food and Drug Administration has approved the antibiotic Zevtera (ceftobiprole medocaril sodium for injection) for three different indications, including treatment of adults with Staphylococcus aureus bloodstream... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 8, 2024 Category: Pharmaceuticals Source Type: news
FDA OKs Injectable Antibiotic for Three Different Uses
(MedPage Today) -- The FDA approved the injectable drug ceftobiprole medocaril sodium (Zevtera) to treat adults with Staphylococcus aureus bacteremia (SAB), the agency announced Wednesday.
The antibiotic prodrug is indicated for people with right... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - April 3, 2024 Category: American Health Source Type: news
FDA Approves New Antibiotic for Three Different Uses
The FDA approved a new antibiotic for the treatment of certain patients with Staphylococcus aureus bloodstream infections, including those with right-sided infective endocarditis; acute bacterial skin and skin structure infections; and community-acquired bacterial pneumonia. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 3, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Staph Infections Appear to Be More Deadly for Women
(MedPage Today) -- Female patients with Staphylococcus aureus bacteremia (SAB) had higher mortality risk than male patients, according to a systematic review and meta-analysis.
In adjusted mortality data from 32 studies accounting for additional... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - February 27, 2024 Category: Infectious Diseases Source Type: news
Oral Switch Noninferior for Low-Risk S. Aureus Bloodstream Infection
FRIDAY, Jan. 26, 2024 -- For patients with low-risk Staphylococcus aureus (S. aureus) bloodstream infection, early switch to oral antimicrobial therapy is noninferior to intravenous standard therapy, according to a study published online Jan. 17 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 26, 2024 Category: Pharmaceuticals Source Type: news
Switch to Oral Antibiotics Noninferior in Low-Risk Staph Bloodstream Infections
(MedPage Today) -- An early switch to oral antibiotics in patients hospitalized with low-risk Staphylococcus aureus bloodstream infection was noninferior to IV antibiotics, according to the randomized controlled SABATO trial.
In the trial's intention... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - January 20, 2024 Category: Infectious Diseases Source Type: news
Deep Learning AI Finds New Class of Antibiotic Candidates
The newly discovered compounds can kill methicillin-resistant Staphylococcus aureus (MRSA), a bacterium that causes deadly infections (Source: Disabled World)
Source: Disabled World - December 20, 2023 Category: Disability Tags: AI and Disabilities Source Type: news
Harvard study may have finally solved mystery of what causes persistent itching - and one in THREE Americans have it
Scientists at Harvard University have discovered that itchiness in conditions like eczema could be due to a form of bacteria called Staphylococcus aureus, which is carried by one in three Americans. (Source: the Mail online | Health)
Source: the Mail online | Health - November 22, 2023 Category: Consumer Health News Source Type: news
Immunity-enhancing cocktail protects mice against multiple hospital germs
Some people in hospital die not from the illness or accident that got them admitted but from germs they catch once there. In the United States alone, there are hundreds of thousands of hospital-acquired infections each year, leading to tens of thousands of deaths. Seeking to lower this toll, researchers have now come up with an
immune-boosting cocktail that increases the survival
of mice exposed to the microbes responsible.
The three-compound formulation, which the researchers unusually refer to as a vaccine, provided up to 28 days of protection from the notorious hospital bacterium
Pseudomonas aerugin...
Source: ScienceNOW - October 4, 2023 Category: Science Source Type: news
Ceftobiprole Noninferior to Daptomycin for Complicated Staph Infection
WEDNESDAY, Oct. 4, 2023 -- For patients with complicated Staphylococcus aureus bacteremia, ceftobiprole is noninferior to daptomycin for overall treatment success, according to a study published online Sept. 27 in the New England Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 4, 2023 Category: Pharmaceuticals Source Type: news
Basilea Announces FDA Acceptance of New Drug Application for Antibiotic Ceftobiprole
Seeking approval for Staphylococcus aureus bacteremia (SAB), acute bacterial skin and skin structure infections (ABSSSI), and community-acquired bacterial pneumonia (CABP)
Prescription Drug User Fee Act (PDUFA) goal date set for April 03,... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - October 2, 2023 Category: Drugs & Pharmacology Source Type: news
Newer Antibiotic Effective Against Deadly Staph Infection Newer Antibiotic Effective Against Deadly Staph Infection
An antibiotic already in use in Europe to treat pneumonia controlled deadly bloodstream infections with Staphylococcus aureus bacteria just as effectively as the most powerful antibiotic currently in use, according to data from a late-stage trial.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 28, 2023 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
How Many Diphtheria Vaccines are Currently Licensed in the US?
Discussion
Diphtheria is caused by the toxin produced by Corynebacterium diphtheriae. Two other Corynebacterium species (C. ulcerans and C. pseudotuberculosis) may produce diphtheria toxin; both species are zoonotic. Diphtheria is spread by respiratory droplets and also contact with open ulcers or sores. Incubation period is 1-10 days with a usual period of 2-5 days. The bacteria attacks the respiratory tract mucosa causing cellular death which in turn causes a “pseudomembrane” of tissue to build up causing respiratory distress and possible death due to airway obstruction (5-10% for general population but up to...
Source: PediatricEducation.org - September 25, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Investigating turf burn-related videos on TikTok: cross-sectional study - Hong BJU, Woo BKP.
BACKGROUND: Due to the increased use of artificial turf, turf burn has become a common sports injury. Turf burn is caused by exposed skin sliding on artificial turf. Health complications, such as methicillin-resistant Staphylococcus aureus outbreaks, sepsi... (Source: SafetyLit)
Source: SafetyLit - August 28, 2023 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news
